Facebook
Twitter
LinkedIn
ForwardMCI Radiation Oncology Grand Rounds- Pancreatic Cancer and Radiotherapy: Progress and Future Direction
Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth leading cause of cancer-related death in North America. Most patients present with locally advanced or metastatic disease that precludes curative resection.
During this conference Dr. Tuli will discuss the emerging treatment strategies in pancreatic cancer, including the role of immunotherapy.
Target Audience
Radiation Oncologists, Medical Oncologists, Oncology Surgeons and Radiologists
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Learning Objectives
- Describe the genomic complexity and molecular heterogeneity of pancreatic cancer.
- Identify multimodality treatment strategies for localized resectable, borderline and unresectable pancreatic cancer.
- Implement emerging treatment strategies in pancreatic cancer, including the role of immunotherapy.
Richard Tuli, M.D., Ph.D.
Associate Attending
Director of Development Therapeutics
Radiation Oncology
Memorial Sloan Kettering Cancer Center
Richard Tuli, M.D. , Ph.D., indicated that he is a consultant with AstraZeneca. He has received grant/research support from Abbvie and Phase One. He will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Michael D. Chuong, M.D.
Radiation Oncologist
Baptist Health Quality Network
Baptist and South Miami Hospitals
Miami, Florida
Dr. Chuong has indicated he has received grant/research support from AstraZeneca and ViewRay. He is on the speakers' bureau for Viewray, Accuray and Sirtex and his discussion will not include mention of investigational or off-label usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-621028, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurses and Nurse Practitioners. Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.